Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 5 institutions in 1 country.
Liisa ViitasaloCentre for Child Health Research, Tampere University, and Department of Pediatrics, Tampere University Hospital, FI-33521 Tampere, Finland.
Sari IltanenCentre for Child Health Research, Tampere University, and Department of Pediatrics, Tampere University Hospital, FI-33521 Tampere, Finland.
Heini HuhtalaFaculty of Social Sciences, Tampere University, FI-33520 Tampere, Finland.
Päivi SaavalainenResearch Program Unit, Immunobiology, and Department of Medical and Clinical Genetics, University of Helsinki, FI-00014 Helsinki, Finland.
Katri KaukinenCeliac Disease Research Centre, Faculty of Medicine and Health Technology, Tampere University, FI-33520 Tampere, Finland.
Katri LindforsCeliac Disease Research Centre, Faculty of Medicine and Health Technology, Tampere University, FI-33520 Tampere, Finland.
Kalle KurppaCentre for Child Health Research, Tampere University, and Department of Pediatrics, Tampere University Hospital, FI-33521 Tampere, Finland.
Tampere University · FIHelsinki University Hospital · FILapland Central Hospital · FISeinäjoki University of Applied Sciences · FIUniversity of Helsinki · FI
Funding
Academy of Finland NAPäivikki ja Sakari Sohlbergin Säätiö NASigrid Juséliuksen Säätiö NAthe Competitive State Research Financing of the Expert Area of Tampere University Hospital NAthe Finnish Medical Foundation NAthe Foundation for Pediatric Research NAthe Paulo Foundation NA
6 · The paper itself
Abstract
Risk of celiac disease (CD) is increased in relatives of CD patients due to genetic and possible environmental factors. We recently reported increased seropositivity to anti-
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
First-degree Relatives of Celiac Disease Patients Have Increased Seroreactivity to Serum Microbial Markers. · full record | OpenQuestion